Australian Pharmaceuticals & Biotech Breakout Stocks

Results

4 new

Stocks where the price continues to rise after more than a year of consistent gains.

4 companies

Neuren Pharmaceuticals

Market Cap: AU$2.4b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

NEU

AU$21.64

26.3%

27.2%

PYC Therapeutics

Market Cap: AU$2.0b

A drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.

PYC

AU$2.10

29.2%

61.5%

Nyrada

Market Cap: AU$183.9m

A pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular and neurological diseases.

NYR

AU$0.74

37.0%

155.2%

Vectus Biosystems

Market Cap: AU$8.0m

Engages in the medical research and development activities in Australia.

VBS

AU$0.16

23.1%

166.7%